(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HEARTBEAT.BIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

HEARTBEAT.BIO

ST13

US500000079332382

Classe

1, 9, 42

Pedido

79332382

Registro

7082556

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

04/11/2023

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 9, 42

Data de depósito

13/10/2021

Data de registro

20/06/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/06/2023

Última transação

20/06/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

25

Localização do titular

AT

Examinador

BECHHOFER, YOCHEVED D

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of a red roughly circular shape with a hole in the middle, surrounded by a dark blue circle. To the right of the design is the wording "HEART" stacked on top of the wording "BEAT.BIO" Heart and Bio are dark blue, the period is red, and bio is gray. The color white represents background, outlining, shading, and/or transparent area and is/are not part of the mark.

Titulares e representantes

Titulares

HeartBeat.bio AG

Representantes

Michael J. Leonard Fox Rothschild LLP

Classificação técnica

Classes Nice

Classe 1Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Biological preparations for use in science; biological preparations for use in industry and sciencein particularbiologically active substancesproteinsnucleic acids; kits for biotechnological and chemical research purposes composed of reagents and assay samples; biological preparation for use in cell cultures other than for medical or veterinary use; cell culture media for use in non-medical research laboratories; cell culture media for use in the biotechnological industry for scientific and research use; cell growth media for growing cells for scientific use; reconstituted cells for the tolerance testing of pharmaceutical products for scientific and research purposes; reconstituted cells for the efficiency testing of pharmaceutical products for scientific and research purposes; cell culture reagents for scientific and research use; cell culture media for scientific and research use; stem cells for research or scientific purposes; stem cell cultures for scientific or research use; cell cultures for scientific or research use; cell aggregate cultures for scientific or research use; biological tissue cultures for scientific or research use

Classe 9

Scientific apparatus and instrumentssample carriers and pipetting and dispensing devicesoptical instrumentsbeing laboratory apparatus for research and industrial applicationsfor use in the fields of biotechnologypharmacymedicinediagnostics and chemistryapparatus and instruments for microscopy for use in connection with the generation of three dimensional tissue and cell models and automated high-throughput pipetting systemsincluding manualsemi-automatedautomated pipetting systems; scientific apparatus and instrumentsfor use in the field of development and manufacture of biotechnological goodsbiotechnological processespharmaceutical goodspharmaceutical processesdiagnostic productsdiagnostic processesmicrofluidic technology-based chips which enable investigators to perform co-cultures of multiple cell and tissue types in 3-D with high-throughput screening capabilities for biomedical research and drug discovery; data carriers containing downloadable and recorded computer programs for carrying out high-throughput screeningtissue and cell modelingscientific investigations and experimentsto evaluate the results in the biotechnologypharmaceutical fieldsmedicinediagnosticschemical fields; downloadable and recorded software programs for evaluating experimental data derived from for high-throughput screeningtissue and cell modeling for use in the biotechnologypharmaceutical fieldsmedicinediagnosticschemical fields; testwarerecorded and downloadable software for use in high-throughput screening and tissue and cell modeling; downloadable and recorded software for test systems for carrying out scientific investigations and experiments for use in the biotechnologypharmaceutical fieldsmedicinediagnostics chemical fields; downloadable and recorded computer programs for evaluating experimental data of tests on stem cell cultures of tissue cultures

Classe 42

Research and development services in the field of information technology for the biotechnologypharmacologymedicinemedical diagnosticschemistry industries; stem cell research; development of computer software for biotechnicalpharmaceutical and diagnostic use; development of biotechnicalpharmaceutical and diagnostic products and technical apparatuslaboratory apparatus for research and industrial applicationsapparatus and instruments for microscopymicrofluidic technology-based chips for high-throughput screening and data carriers; medical research; pharmaceutical research services; development of pharmaceutical preparations and medicines; provision of information and data relating to medical and veterinary research and development; computer programming in the medical field; development of computer platforms for screening in the field of medicine; development of chemical and biochemical assay system kits for biotechnological and chemical research purposes; development and establishment of testing specifications and procedures for use in the field of biotechnologypharmacologymedicinediagnosticschemistry; development of software for test systems for use in the field of biotechnologypharmacologymedicinediagnosticschemistry; scientific research and development in the field of diseases and disorders of the heart and in the heart development; scientific research and development of goods for the treatment of heart diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/11/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

21/09/2023

FIMP

FINAL DISPOSITION PROCESSED

21/09/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

20/09/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

20/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

20/06/2023

GPNX

NOTIFICATION PROCESSED BY IB

05/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/04/2023

PUBO

PUBLISHED FOR OPPOSITION

04/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

15/03/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

15/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

15/03/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

28/02/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/02/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

10/02/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/02/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

10/02/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/02/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/01/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/01/2023

RFNT

REFUSAL PROCESSED BY IB

06/09/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/08/2022

RFRR

REFUSAL PROCESSED BY MPU

16/08/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

26/07/2022

CNRT

NON-FINAL ACTION WRITTEN

25/07/2022

DOCK

ASSIGNED TO EXAMINER

19/07/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/02/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HEARTBEAT.BIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.